Mineralys Therapeutics
Dr. Rodman is an experienced industry and academic leader with 15+ years of leadership experience in Pharma and Biotechnology preceded by 15+ years of academic medical experience. Dr. Rodman received his medical degree from the University of Pennsylvania and was subsequently Board Certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine at the University of Colorado. He was elected to the American Society for Clinical Investigation and named an Established Investigator and Fellow of the American Heart Association. Dr. Rodman’s pharmaceutical experience includes roles at: Novartis Institutes for Biomedical Research, Vertex Pharmaceuticals, miRagen, Nivalis and ProQR.
This person is not in any offices
Mineralys Therapeutics
2 followers
At Mineralys Therapeutics, they aim to redefine hypertension diagnosis, management, and treatment. They are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.